Causes and Treatment of Orthostatic Hypotension
The most effective management of orthostatic hypotension requires identifying the underlying cause and implementing a combination of non-pharmacological measures first, followed by pharmacological interventions only when necessary, with midodrine being the most evidence-supported medication for symptomatic cases that don't respond to conservative measures. 1
Definition and Diagnosis
Orthostatic hypotension is characterized by:
- Decrease in systolic blood pressure of ≥20 mmHg or diastolic blood pressure of ≥10 mmHg within three minutes of standing 1, 2
- Symptoms that develop upon standing and are relieved by sitting or lying down 1
Common Causes
Non-neurogenic Causes
- Hypovolemia: Dehydration, blood loss, excessive diuresis
- Cardiovascular: Heart failure, cardiac insufficiency, impaired venous return
- Medications:
Neurogenic Causes
- Primary autonomic disorders:
- Multiple system atrophy
- Pure autonomic failure
- Secondary autonomic disorders:
- Diabetic autonomic neuropathy
- Autoimmune disorders
- Parkinson's disease
- Vitamin deficiencies (B12)
- Thyroid dysfunction
- Paraneoplastic syndromes 1
Treatment Approach
Non-Pharmacological Interventions (First-Line)
Fluid and Salt Management:
- Increased fluid intake (2-3 liters daily)
- Increased salt intake (6-9g daily) 1
Physical Countermeasures:
Positional Modifications:
- Head-up tilt sleeping (10° elevation)
- Avoiding rapid position changes 1
Dietary Modifications:
Environmental Management:
- Maintaining cool environment
- Appropriate clothing 1
Exercise Program:
- Structured progressive reconditioning
- Starting with recumbent exercises and gradually progressing to upright exercises 1
Pharmacological Interventions (When Non-Pharmacological Measures Are Insufficient)
First-Line Medications:
Alternative/Additional Medications:
- Fludrocortisone: 0.1mg daily for cases with suspected hypovolemia
- Droxidopa: 100-600mg three times daily for neurogenic orthostatic hypotension
- Pyridostigmine: 30mg 2-3 times daily for refractory cases
- Octreotide: For refractory recurrent postprandial or neurogenic orthostatic hypotension
- Acarbose: For postprandial hypotension, particularly in patients with autonomic dysfunction 1
Special Considerations
Monitoring
- Regular weight assessment and electrolyte monitoring
- Heart rate monitoring during position changes
- Monitor for supine hypertension by measuring BP in both supine and standing positions 1
Population-Specific Considerations
- Elderly: More vulnerable due to age-related changes in autonomic function
- Diabetic patients: Focus on glucose control alongside orthostatic management
- Heart failure patients: Cautious use of volume-expanding agents
- Renal impairment: Start with lower doses of midodrine (2.5 mg) and monitor closely 1, 3
Common Pitfalls to Avoid
- Focusing on BP numbers rather than symptom improvement
- Overlooking non-pharmacological measures before starting medications
- Improper timing of medications (administering vasopressors too close to bedtime)
- Inadequate monitoring for supine hypertension (all pharmacological treatments can cause or worsen this) 1
- Using midodrine in patients with urinary retention problems, as it acts on alpha-adrenergic receptors of the bladder neck 3
- Using midodrine with other vasoconstrictors without careful BP monitoring 3
Treatment Algorithm
- Identify and address reversible causes (medication adjustment, volume repletion)
- Implement non-pharmacological measures for all patients
- If symptoms persist, add pharmacological therapy:
- Start with midodrine 5mg three times daily (last dose before 6 PM)
- May increase to 10mg three times daily if needed
- Consider adding fludrocortisone 0.1mg daily if volume depletion is suspected
- For refractory cases, consider combination therapy or specialist referral